当前蛋白身份:O14936 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
1KGD Crystal Structure of the Guanylate Kinase-like Domain of Human CASK 提交 2001-11-26 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 734–909(176 aa) 片段:guanylate kinase like domain
未记录 FMT FORMIC ACID × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;sodium formate, potassium chloride, magnesium chloride, Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K
分辨率 1.31 Å R-free 0.212
1KWA HUMAN CASK/LIN-2 PDZ DOMAIN 提交 1998-01-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 487–572(86 aa) 片段:PDZ DOMAIN
未记录 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;294 K;PROTEIN WAS CRYSTALLIZED IN 1.8M AMMONIUM SULFATE AND 100MM MES PH 6.5 AT 21 DEGREES C., temperature 294K
分辨率 1.93 Å R-free 0.298
1KWA HUMAN CASK/LIN-2 PDZ DOMAIN 提交 1998-01-16 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 487–572(86 aa) 片段:PDZ DOMAIN
未记录 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;294 K;PROTEIN WAS CRYSTALLIZED IN 1.8M AMMONIUM SULFATE AND 100MM MES PH 6.5 AT 21 DEGREES C., temperature 294K
分辨率 1.93 Å R-free 0.298
1KWA HUMAN CASK/LIN-2 PDZ DOMAIN 提交 1998-01-16 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 487–572(86 aa) 片段:PDZ DOMAIN
链 B 487–572(86 aa) 片段:PDZ DOMAIN
未记录 SO4 SULFATE ION × 6 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;294 K;PROTEIN WAS CRYSTALLIZED IN 1.8M AMMONIUM SULFATE AND 100MM MES PH 6.5 AT 21 DEGREES C., temperature 294K
分辨率 1.93 Å R-free 0.298
1KWA HUMAN CASK/LIN-2 PDZ DOMAIN 提交 1998-01-16 Assembly 4 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 487–572(86 aa) 片段:PDZ DOMAIN
链 B 487–572(86 aa) 片段:PDZ DOMAIN
未记录 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;294 K;PROTEIN WAS CRYSTALLIZED IN 1.8M AMMONIUM SULFATE AND 100MM MES PH 6.5 AT 21 DEGREES C., temperature 294K
分辨率 1.93 Å R-free 0.298
1KWA HUMAN CASK/LIN-2 PDZ DOMAIN 提交 1998-01-16 Assembly 5 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 487–572(86 aa) 片段:PDZ DOMAIN
链 B 487–572(86 aa) 片段:PDZ DOMAIN
未记录 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;294 K;PROTEIN WAS CRYSTALLIZED IN 1.8M AMMONIUM SULFATE AND 100MM MES PH 6.5 AT 21 DEGREES C., temperature 294K
分辨率 1.93 Å R-free 0.298
1ZL8 NMR structure of L27 heterodimer from C. elegans Lin-7 and H. sapiens Lin-2 scaffold proteins 提交 2005-05-05 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 403–456(54 aa) 片段:L27 domain
未记录 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 8;298 K;离子强度(mmCIF原始值)0;压力 ambient
NMR样品组成 2mM Lin-7/Lin-2C; 20mM HEPES, 5mM TCEP, 0.05% DSS, 0.05% sodium azide, 90% H2O, 10% D2O | 90% D2O, 10% D2O
分辨率未提供
3C0G CASK CaM-Kinase Domain- 3'-AMP complex, P1 form 提交 2008-01-20 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–337(337 aa) 片段:CaM-Kinase Domain
未记录 3AM [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.2;293 K;12.5%(v/v) ethylene glycol, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 2.19 Å R-free 0.270
3C0G CASK CaM-Kinase Domain- 3'-AMP complex, P1 form 提交 2008-01-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–337(337 aa) 片段:CaM-Kinase Domain
未记录 3AM [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.2;293 K;12.5%(v/v) ethylene glycol, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 2.19 Å R-free 0.270
3C0H CASK CaM-Kinase Domain- AMPPNP complex, P1 form 提交 2008-01-20 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–337(337 aa) 片段:CaM-Kinase Domain
未记录 AMP ADENOSINE MONOPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.2;293 K;12.5%(v/v) ethylene glycol, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 2.30 Å R-free 0.239
3C0H CASK CaM-Kinase Domain- AMPPNP complex, P1 form 提交 2008-01-20 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–337(337 aa) 片段:CaM-Kinase Domain
未记录 AMP ADENOSINE MONOPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.2;293 K;12.5%(v/v) ethylene glycol, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 2.30 Å R-free 0.239
3C0I CASK CaM-Kinase Domain- 3'-AMP complex, P212121 form 提交 2008-01-20 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–337(337 aa) 片段:CaM-Kinase Domain
未记录 3AM [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.2;293 K;12.5%(v/v) ethylene glycol, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 1.85 Å R-free 0.234
3MFR CASK-4M CaM Kinase Domain, native 提交 2010-04-03 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–337(337 aa) 片段:CASK-4M CaM kinase domain, residues 1-337
突变:Pro22Ala, His145Glu, Gly162Asp, Cys146Asn ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.2;293 K;12.5 % (v/v) ethylene glycol, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 2.00 Å R-free 0.241
3MFS CASK-4M CaM Kinase Domain, AMPPNP 提交 2010-04-03 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–337(337 aa) 片段:CASK-4M CaM kinase domain, rersidues 1-337
突变:Pro22Ala, His145Glu, Gly162Asp, Cys146Asn ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.2;293 K;12.5 % (v/v) ethylene glycol, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 2.10 Å R-free 0.268
3MFT CASK-4M CaM Kinase Domain, Mn2+ 提交 2010-04-03 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–337(337 aa) 片段:CASK-4M CaM kinase domain, residues 1-337
突变:Pro22Ala, His145Glu, Gly162Asp, Cys146Asn 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.2;293 K;12.5 % (v/v) ethylene glycol, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 2.20 Å R-free 0.270
3MFU CASK-4M CaM Kinase Domain, AMPPNP-Mn2+ 提交 2010-04-03 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–337(337 aa) 片段:CASK-4M CaM kinase domain, residues 1-337
突变:Pro22Ala, His145Glu, Gly162Asp, Cys146Asn ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 MN MANGANESE (II) ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.2;293 K;12.5 % (v/v) ethylene glycol, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 2.30 Å R-free 0.234
3TAC Crystal Structure of the Liprin-alpha/CASK complex 提交 2011-08-03 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–345(345 aa) 片段:UNP residues 1-345
未记录 SO4 SULFATE ION × 7 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;289 K;1.4M ammonium sulfate, 0.2M NaCl, MES buffer, pH 6.5, vapor diffusion, hanging drop, temperature 289K
分辨率 2.20 Å R-free 0.236
6KMH The crystal structure of CASK/Mint1 complex 提交 2019-07-31 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–319(319 aa)
未记录 IOD IODIDE ION × 7 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;289 K;0.2M KI, 20% PEG 3350, pH 7.0
分辨率 2.40 Å R-free 0.224
6KMH The crystal structure of CASK/Mint1 complex 提交 2019-07-31 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 1–319(319 aa)
未记录 IOD IODIDE ION × 5 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;289 K;0.2M KI, 20% PEG 3350, pH 7.0
分辨率 2.40 Å R-free 0.224
6NH9 Crystal structure of a human calcium/calmodulin dependent serine protein kinase (CASK) PDZ domain 提交 2018-12-21 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 102–187(86 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 10.5;291 K;30% v/v PEG 400 0.1M CAPS
分辨率 1.85 Å R-free 0.263
6NH9 Crystal structure of a human calcium/calmodulin dependent serine protein kinase (CASK) PDZ domain 提交 2018-12-21 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 102–187(86 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 10.5;291 K;30% v/v PEG 400 0.1M CAPS
分辨率 1.85 Å R-free 0.263
6NH9 Crystal structure of a human calcium/calmodulin dependent serine protein kinase (CASK) PDZ domain 提交 2018-12-21 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 102–187(86 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 10.5;291 K;30% v/v PEG 400 0.1M CAPS
分辨率 1.85 Å R-free 0.263
6NID Crystal structure of a human calcium/calmodulin dependent serine protein kinase (CASK) PDZ domain in complex with Neurexin-1 peptide 提交 2018-12-27 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 102–187(86 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;0.01M tri-sodium citrate 33% (w/v) PEG 6000
分辨率 1.86 Å R-free 0.240
6NID Crystal structure of a human calcium/calmodulin dependent serine protein kinase (CASK) PDZ domain in complex with Neurexin-1 peptide 提交 2018-12-27 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 102–187(86 aa)
未记录 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;0.01M tri-sodium citrate 33% (w/v) PEG 6000
分辨率 1.86 Å R-free 0.240
6NID Crystal structure of a human calcium/calmodulin dependent serine protein kinase (CASK) PDZ domain in complex with Neurexin-1 peptide 提交 2018-12-27 Assembly 3 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 102–187(86 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;0.01M tri-sodium citrate 33% (w/v) PEG 6000
分辨率 1.86 Å R-free 0.240
7OAI Crystal structure of pseudokinase CASK in complex with PFE-PKIS12 提交 2021-04-19 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–337(337 aa)
未记录 V5W 4-(Cyclopentylamino)-2-[(2,5-dichlorophenyl)methylamino]-N-[3-(2-oxo-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;12% high molecular weight PEG Smears, 0.1 M MES pH 6.0, 0.1 M magnesium acetate, 0.1 M KCl
分辨率 2.30 Å R-free 0.213
7OAI Crystal structure of pseudokinase CASK in complex with PFE-PKIS12 提交 2021-04-19 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–337(337 aa)
未记录 V5W 4-(Cyclopentylamino)-2-[(2,5-dichlorophenyl)methylamino]-N-[3-(2-oxo-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;12% high molecular weight PEG Smears, 0.1 M MES pH 6.0, 0.1 M magnesium acetate, 0.1 M KCl
分辨率 2.30 Å R-free 0.213
7OAI Crystal structure of pseudokinase CASK in complex with PFE-PKIS12 提交 2021-04-19 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–337(337 aa)
未记录 V5W 4-(Cyclopentylamino)-2-[(2,5-dichlorophenyl)methylamino]-N-[3-(2-oxo-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;12% high molecular weight PEG Smears, 0.1 M MES pH 6.0, 0.1 M magnesium acetate, 0.1 M KCl
分辨率 2.30 Å R-free 0.213
7OAI Crystal structure of pseudokinase CASK in complex with PFE-PKIS12 提交 2021-04-19 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–337(337 aa)
未记录 V5W 4-(Cyclopentylamino)-2-[(2,5-dichlorophenyl)methylamino]-N-[3-(2-oxo-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;12% high molecular weight PEG Smears, 0.1 M MES pH 6.0, 0.1 M magnesium acetate, 0.1 M KCl
分辨率 2.30 Å R-free 0.213
7OAJ Crystal structure of pseudokinase CASK in complex with compound 7 提交 2021-04-19 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–337(337 aa)
未记录 V6E 4-(cyclopentylamino)-2-[(3,4-dichlorophenyl)methylamino]-N-[3-(2-oxidanylidenepyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293.15 K;9% medium molecular weight PED Smears, 0.1 M magnesium acetate, 10% ethylene glycol, 0.1 M MES, pH 6.5
分辨率 1.93 Å R-free 0.224
7OAJ Crystal structure of pseudokinase CASK in complex with compound 7 提交 2021-04-19 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–337(337 aa)
未记录 V6E 4-(cyclopentylamino)-2-[(3,4-dichlorophenyl)methylamino]-N-[3-(2-oxidanylidenepyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 8 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293.15 K;9% medium molecular weight PED Smears, 0.1 M magnesium acetate, 10% ethylene glycol, 0.1 M MES, pH 6.5
分辨率 1.93 Å R-free 0.224
7OAJ Crystal structure of pseudokinase CASK in complex with compound 7 提交 2021-04-19 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–337(337 aa)
未记录 V6E 4-(cyclopentylamino)-2-[(3,4-dichlorophenyl)methylamino]-N-[3-(2-oxidanylidenepyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293.15 K;9% medium molecular weight PED Smears, 0.1 M magnesium acetate, 10% ethylene glycol, 0.1 M MES, pH 6.5
分辨率 1.93 Å R-free 0.224
7OAJ Crystal structure of pseudokinase CASK in complex with compound 7 提交 2021-04-19 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–337(337 aa)
未记录 V6E 4-(cyclopentylamino)-2-[(3,4-dichlorophenyl)methylamino]-N-[3-(2-oxidanylidenepyrrolidin-1-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293.15 K;9% medium molecular weight PED Smears, 0.1 M magnesium acetate, 10% ethylene glycol, 0.1 M MES, pH 6.5
分辨率 1.93 Å R-free 0.224
7OAK Crystal structure of pseudokinase CASK in complex with compound 26 提交 2021-04-19 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–337(337 aa)
未记录 V6B 2-[[2,5-bis(bromanyl)-4-methyl-phenyl]methylamino]-4-(cyclopentylamino)-N-[3-(2-oxidanylidene-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;12% high molecular weight PEG Smears, 0.1 M magnesium acetate, 0.1 M MES, pH 6.0
分辨率 2.23 Å R-free 0.264
7OAK Crystal structure of pseudokinase CASK in complex with compound 26 提交 2021-04-19 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–337(337 aa)
未记录 V6B 2-[[2,5-bis(bromanyl)-4-methyl-phenyl]methylamino]-4-(cyclopentylamino)-N-[3-(2-oxidanylidene-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;12% high molecular weight PEG Smears, 0.1 M magnesium acetate, 0.1 M MES, pH 6.0
分辨率 2.23 Å R-free 0.264
7OAK Crystal structure of pseudokinase CASK in complex with compound 26 提交 2021-04-19 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–337(337 aa)
未记录 V6B 2-[[2,5-bis(bromanyl)-4-methyl-phenyl]methylamino]-4-(cyclopentylamino)-N-[3-(2-oxidanylidene-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;12% high molecular weight PEG Smears, 0.1 M magnesium acetate, 0.1 M MES, pH 6.0
分辨率 2.23 Å R-free 0.264
7OAK Crystal structure of pseudokinase CASK in complex with compound 26 提交 2021-04-19 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–337(337 aa)
未记录 V6B 2-[[2,5-bis(bromanyl)-4-methyl-phenyl]methylamino]-4-(cyclopentylamino)-N-[3-(2-oxidanylidene-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;12% high molecular weight PEG Smears, 0.1 M magnesium acetate, 0.1 M MES, pH 6.0
分辨率 2.23 Å R-free 0.264
7OAL Crystal structure of pseudokinase CASK in complex with compound 25 提交 2021-04-19 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–337(337 aa)
未记录 V62 2-[[2,5-bis(bromanyl)-4-methyl-phenyl]methylamino]-4-(cyclohexylamino)-N-[3-(2-oxidanylidene-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;9% high molecular weight PEG Smears, 0.1 M magnesium acetate, 0.1 M KCl, 0.1 M MES, pH 6.0
分辨率 2.17 Å R-free 0.274
7OAL Crystal structure of pseudokinase CASK in complex with compound 25 提交 2021-04-19 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–337(337 aa)
未记录 V62 2-[[2,5-bis(bromanyl)-4-methyl-phenyl]methylamino]-4-(cyclohexylamino)-N-[3-(2-oxidanylidene-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;9% high molecular weight PEG Smears, 0.1 M magnesium acetate, 0.1 M KCl, 0.1 M MES, pH 6.0
分辨率 2.17 Å R-free 0.274
7OAL Crystal structure of pseudokinase CASK in complex with compound 25 提交 2021-04-19 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–337(337 aa)
未记录 V62 2-[[2,5-bis(bromanyl)-4-methyl-phenyl]methylamino]-4-(cyclohexylamino)-N-[3-(2-oxidanylidene-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;9% high molecular weight PEG Smears, 0.1 M magnesium acetate, 0.1 M KCl, 0.1 M MES, pH 6.0
分辨率 2.17 Å R-free 0.274
7OAL Crystal structure of pseudokinase CASK in complex with compound 25 提交 2021-04-19 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–337(337 aa)
未记录 V62 2-[[2,5-bis(bromanyl)-4-methyl-phenyl]methylamino]-4-(cyclohexylamino)-N-[3-(2-oxidanylidene-1,3-oxazolidin-3-yl)propyl]pyrimidine-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;9% high molecular weight PEG Smears, 0.1 M magnesium acetate, 0.1 M KCl, 0.1 M MES, pH 6.0
分辨率 2.17 Å R-free 0.274
8Y68 the crystal structure of apo CASK-CaMK 提交 2024-02-02 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–332(332 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;289 K;0.1 M Sodium citrate tribasic dihydrate, pH 5.0, 10% (v/v) PEG6000.
分辨率 2.20 Å R-free 0.264
8Y68 the crystal structure of apo CASK-CaMK 提交 2024-02-02 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–332(332 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;289 K;0.1 M Sodium citrate tribasic dihydrate, pH 5.0, 10% (v/v) PEG6000.
分辨率 2.20 Å R-free 0.264
9KYS the Ca2+/CaM-CASK-ARD complex 提交 2024-12-09 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 B 287–332(46 aa)
链 D 287–332(46 aa)
未记录 CA CALCIUM ION × 8 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;289 K;magnesium chloride, PEG 3350
分辨率 1.76 Å R-free 0.231
9M5Y the crystal structure of the Ca2+/CaM-CASK-CaMK complex 提交 2025-03-06 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–332(332 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 PO4 PHOSPHATE ION × 1 CA CALCIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;298 K;0.1 M Sodium citrate tribasic dihydrate, pH 5.0, 10% (v/v) PEG 6000.
分辨率 1.80 Å R-free 0.197
9M6G the crystal structure of the Ca2+/CaM-CASK-CaMK-Mint1-CID complex 提交 2025-03-07 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 1–319(319 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 MLI MALONATE ION × 1 CA CALCIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5;289 K;0.1 M Sodium malonate, pH 5.0, 12% (v/v) PEG 3350
分辨率 1.70 Å R-free 0.187